These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

442 related articles for article (PubMed ID: 35109817)

  • 1. Comparison of cardiovascular magnetic resonance characteristics and clinical prognosis in left ventricular noncompaction patients with and without arrhythmia.
    Zhou ZQ; He WC; Li X; Bai W; Huang W; Hou RL; Wang YN; Guo YK
    BMC Cardiovasc Disord; 2022 Feb; 22(1):25. PubMed ID: 35109817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myocardial scar predicts monomorphic ventricular tachycardia but not polymorphic ventricular tachycardia or ventricular fibrillation in nonischemic dilated cardiomyopathy.
    Piers SR; Everaerts K; van der Geest RJ; Hazebroek MR; Siebelink HM; Pison LA; Schalij MJ; Bekkers SC; Heymans S; Zeppenfeld K
    Heart Rhythm; 2015 Oct; 12(10):2106-14. PubMed ID: 26004942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conductive channels identified with contrast-enhanced MR imaging predict ventricular tachycardia in systolic heart failure.
    Lin LY; Su MY; Chen JJ; Lai LP; Hwang JJ; Tseng CD; Chen YS; Yu HY; Tseng WY; Lin JL
    JACC Cardiovasc Imaging; 2013 Nov; 6(11):1152-9. PubMed ID: 24229767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of the presence and amount of myocardial fibrosis by cardiac magnetic resonance on arrhythmic outcome and sudden cardiac death in nonischemic dilated cardiomyopathy.
    Perazzolo Marra M; De Lazzari M; Zorzi A; Migliore F; Zilio F; Calore C; Vettor G; Tona F; Tarantini G; Cacciavillani L; Corbetti F; Giorgi B; Miotto D; Thiene G; Basso C; Iliceto S; Corrado D
    Heart Rhythm; 2014 May; 11(5):856-63. PubMed ID: 24440822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-Term Prognostic Value of Cardiac Magnetic Resonance in Left Ventricle Noncompaction: A Prospective Multicenter Study.
    Andreini D; Pontone G; Bogaert J; Roghi A; Barison A; Schwitter J; Mushtaq S; Vovas G; Sormani P; Aquaro GD; Monney P; Segurini C; Guglielmo M; Conte E; Fusini L; Dello Russo A; Lombardi M; Gripari P; Baggiano A; Fiorentini C; Lombardi F; Bartorelli AL; Pepi M; Masci PG
    J Am Coll Cardiol; 2016 Nov; 68(20):2166-2181. PubMed ID: 27855806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of cardiac magnetic resonance imaging parameters in left ventricular noncompaction with left ventricular dysfunction.
    Bai W; Xu R; Li X; Xu H; Fu H; Hou R; Zhou Z; Huang W; Wang Y; Guo Y
    BMC Cardiovasc Disord; 2022 Dec; 22(1):526. PubMed ID: 36474142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular magnetic resonance imaging pattern in patients with autoimmune rheumatic diseases and ventricular tachycardia with preserved ejection fraction.
    Mavrogeni SI; Sfikakis PP; Markousis-Mavrogenis G; Bournia VK; Poulos G; Koutsogeorgopoulou L; Karabela G; Stavropoulos E; Katsifis G; Boki K; Vartela V; Kolovou G; Theodorakis G; Kitas GD
    Int J Cardiol; 2019 Jun; 284():105-109. PubMed ID: 30404725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of cardiovascular magnetic resonance characteristics and clinical consequences in children and adolescents with isolated left ventricular non-compaction with and without late gadolinium enhancement.
    Cheng H; Lu M; Hou C; Chen X; Li L; Wang J; Yin G; Chen X; Xiangli W; Cui C; Chu J; Zhang S; Prasad SK; Pu J; Zhao S
    J Cardiovasc Magn Reson; 2015 May; 17(1):44. PubMed ID: 26024839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantifying late gadolinium enhancement on CMR provides additional prognostic information in early risk-stratification of nonischemic cardiomyopathy: a cohort study.
    Pöyhönen P; Kivistö S; Holmström M; Hänninen H
    BMC Cardiovasc Disord; 2014 Aug; 14():110. PubMed ID: 25160650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic role of CMR in patients presenting with ventricular arrhythmias.
    Dawson DK; Hawlisch K; Prescott G; Roussin I; Di Pietro E; Deac M; Wong J; Frenneaux MP; Pennell DJ; Prasad SK
    JACC Cardiovasc Imaging; 2013 Mar; 6(3):335-44. PubMed ID: 23433931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Entropy as a novel predictor of cardiovascular events in patients with left ventricular noncompaction.
    Gao Y; Liu M; Ju Z; Wang H; Gu H; Wang X
    Int J Cardiol; 2023 Dec; 392():131279. PubMed ID: 37598912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and Prognostic Impact of Septal Late Gadolinium Enhancement in Acute Myocarditis With or Without Preserved Left Ventricular Function.
    Imazio M; Angelico G; Andriani M; Lobetti-Bodoni L; Davini O; Giustetto C; Rinaldi M
    Am J Cardiol; 2018 Dec; 122(11):1955-1958. PubMed ID: 30266253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and prognostic significance of left ventricular myocardial late gadolinium enhancement in severe aortic stenosis.
    Rajesh GN; Thottian JJ; Subramaniam G; Desabandhu V; Sajeev CG; Krishnan MN
    Indian Heart J; 2017; 69(6):742-750. PubMed ID: 29174252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of cardiovascular magnetic resonance in patients with biopsy-proven systemic sarcoidosis.
    Flamée L; Symons R; Degtiarova G; Dresselaers T; Gheysens O; Wuyts W; Van Cleemput J; Bogaert J
    Eur Radiol; 2020 Jul; 30(7):3702-3710. PubMed ID: 32166494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of cardiovascular magnetic resonance imaging for life-threatening arrhythmia detected by implantable cardioverter-defibrillator in Japanese patients with hypertrophic cardiomyopathy.
    Hen Y; Tsugu-Yagawa M; Iguchi N; Utanohara Y; Takada K; Machida H; Takara A; Teraoka K; Inoue K; Takamisawa I; Takayama M; Yoshikawa T
    Heart Vessels; 2018 Jan; 33(1):49-57. PubMed ID: 28766047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can left ventricular entropy by cardiac magnetic resonance late gadolinium enhancement be a prognostic predictor in patients with left ventricular non-compaction?
    Ma YT; Wang LJ; Zhao XY; Zheng Y; Sha LH; Zhao XX
    Diagn Interv Radiol; 2023 Sep; 29(5):682-690. PubMed ID: 36995015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Meta-Analysis of the Prognostic Role of Late Gadolinium Enhancement and Global Systolic Impairment in Left Ventricular Noncompaction.
    Grigoratos C; Barison A; Ivanov A; Andreini D; Amzulescu MS; Mazurkiewicz L; De Luca A; Grzybowski J; Masci PG; Marczak M; Heitner JF; Schwitter J; Gerber BL; Emdin M; Aquaro GD
    JACC Cardiovasc Imaging; 2019 Nov; 12(11 Pt 1):2141-2151. PubMed ID: 30878415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of systolic and diastolic criteria for isolated LV noncompaction in CMR.
    Stacey RB; Andersen MM; St Clair M; Hundley WG; Thohan V
    JACC Cardiovasc Imaging; 2013 Sep; 6(9):931-40. PubMed ID: 23769489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CMR quantification of myocardial scar provides additive prognostic information in nonischemic cardiomyopathy.
    Neilan TG; Coelho-Filho OR; Danik SB; Shah RV; Dodson JA; Verdini DJ; Tokuda M; Daly CA; Tedrow UB; Stevenson WG; Jerosch-Herold M; Ghoshhajra BB; Kwong RY
    JACC Cardiovasc Imaging; 2013 Sep; 6(9):944-54. PubMed ID: 23932642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of Myocardial Disarray in Patients With Hypertrophic Cardiomyopathy and Ventricular Arrhythmias.
    Ariga R; Tunnicliffe EM; Manohar SG; Mahmod M; Raman B; Piechnik SK; Francis JM; Robson MD; Neubauer S; Watkins H
    J Am Coll Cardiol; 2019 May; 73(20):2493-2502. PubMed ID: 31118142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.